roche peptide four obesity peptides in development - Roche罗氏 peptide Roche's Expanding Footprint in Peptide Therapeutics and Diagnostics

罗氏制药 Roche's involvement with peptides spans a considerable range, from cutting-edge drug development in areas like obesity and diabetes to essential diagnostic tools and even skincareSenior Principal Scientist, Peptide Therapeutics @ Roche. The company is actively engaged in leveraging peptide technology to address significant health challenges, as evidenced by its investments and research initiatives in peptide therapeutics. Simultaneously, Roche's diagnostic division utilizes peptides, such as C-peptide, for crucial medical assessments. This dual focus highlights Roche's comprehensive strategy in the peptide landscape, aiming to innovate in both treatment and diagnosis.

Peptide Therapeutics: A Growing Frontier for Roche

A significant area of focus for Roche is the development of peptide-based therapeutics, particularly in the realm of metabolic diseases.Elecsys® C-Peptide The company has made substantial strides in obesity treatment, with its dual GLP-1/GIP receptor agonist CT-388 showing promising results in clinical trials, demonstrating robust weight lossAbbVie to buy Roche spinout for 0 million - C&EN. This development positions Roche to compete in a rapidly growing market. Further solidifying its commitment, Roche has entered into significant collaborations and acquisitions. A notable example is the deal with Zealand Pharma, gaining access to petrelintide, an amylin analog with potential for treating metabolic disorders.2025年5月13日—Stéphane is the founder and CEO of AdaptBio Therapeutics (Est. in 2024). He has 15+ yrs of experience in synthetic and medicinal chemistry ... Roche is responsible for the manufacturing and supply of this engineered peptide, underscoring its strategic intent to control the production pipeline.

Roche's interest in peptide technology also extends to collaborations aimed at developing novel drug delivery systems and therapeutic modalities. Agreements with companies like PeptiDream focus on peptide-radioisotope conjugates for targeted therapies, and the evaluation of peptide technology from firms like Phylogica indicates a broad exploration of the field.Roche GLP-1 produces “robust” weight loss in late-stage obesity trial Furthermore, Roche has been involved in the development of oral peptide treatments through its spinout, Nimble Therapeutics, which was acquired by AbbVie. The company is also exploring peptides for other indications, including a cyclic peptide targeting KRAS, currently in Phase I clinical trials2025年5月28日—Rochesays the trial is expected to launch at the end of the year or in early 2026. Zosurabalpin is a tethered macrocyclicpeptide(MCP) .... The establishment of roles like "Senior Principal Scientist, Peptide Therapeutics" within Roche further signals a dedicated and growing internal effort in this domain.

Diagnostic Applications: The Role of C-Peptide

Beyond therapeutics, Roche plays a critical role in peptide-based diagnostics. The Elecsys® C-Peptide assay is a key diagnostic tool for the in vitro quantitative determination of C-peptide in human samples like serum, plasma, and urineToleriane Ultra Dermallergo Hydrating Serum 30ml. C-peptide, a byproduct of insulin production, is essential for assessing pancreatic beta-cell function and insulin secretion. This assay is vital for aiding in the diagnosis and treatment of patients with abnormal insulin secretion, making it a cornerstone in managing conditions like diabetes2025年5月28日—Rochesays the trial is expected to launch at the end of the year or in early 2026. Zosurabalpin is a tethered macrocyclicpeptide(MCP) .... Roche's development of monoclonal antibodies directed to human C-peptide, such as MABM-RCPT3F11 IgG, further supports the accuracy and efficacy of these diagnostic tests.

Broader Peptide Connections and Research

Roche's engagement with peptides is not limited to its commercial products and major R&D initiatives. The company's research groups are involved in fundamental areas of chemistry, including the total synthesis of complex natural products, which often involves peptide structures. Academic researchers affiliated with institutions often linked to Roche, such as those studying lymphocyte activation by antigen-presenting cells, may also explore peptide-related mechanismsCheck out thePeptidefor Life initiative addressing low adoption of natriureticpeptidesin the emergency departments in Europe.. Additionally, the La Roche-Posay brand, while distinct from the pharmaceutical giant, also incorporates peptides into its skincare lines, highlighting the broader recognition of peptides' benefits, albeit in a different sector. The "Peptide for Life" initiative, addressing the adoption of natriuretic peptides in emergency departments, also underscores the diverse applications and ongoing interest in peptide science.2025年4月22日—The deal terms makeRocheresponsible for manufacturing and supplying that engineeredpeptide, petrelintide. Once the new and expanded ...